Literature DB >> 30991920

Nose-to-brain delivery of biologics.

Bettina Schwarz1, Olivia M Merkel1.   

Abstract

Graphical abstract.

Keywords:  CNS drug delivery; intranasal drug administration-biologics; nanocarriers; nose-to-brain delivery; olfactory epithelium; transport mechanisms

Mesh:

Substances:

Year:  2019        PMID: 30991920     DOI: 10.4155/tde-2019-0013

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  5 in total

Review 1.  Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels.

Authors:  Sara Cunha; Ben Forbes; José Manuel Sousa Lobo; Ana Catarina Silva
Journal:  Int J Nanomedicine       Date:  2021-06-29

2.  Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.

Authors:  Sara Cunha; Cláudia Pina Costa; Joana A Loureiro; Jorge Alves; Andreia F Peixoto; Ben Forbes; José Manuel Sousa Lobo; Ana Catarina Silva
Journal:  Pharmaceutics       Date:  2020-06-28       Impact factor: 6.321

Review 3.  Intranasal drug delivery: opportunities and toxicologic challenges during drug development.

Authors:  Lea-Adriana Keller; Olivia Merkel; Andreas Popp
Journal:  Drug Deliv Transl Res       Date:  2021-01-25       Impact factor: 4.617

Review 4.  Intranasal Insulin for Alzheimer's Disease.

Authors:  Manfred Hallschmid
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

Review 5.  Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis.

Authors:  Jorge Matías-Guiu; Jordi A Matías-Guiu; Paloma Montero-Escribano; Juan A Barcia; Alejandro A Canales-Aguirre; Juan C Mateos-Diaz; Ulises Gómez-Pinedo
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.